{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:48:03Z","timestamp":1761126483174},"reference-count":28,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T00:00:00Z","timestamp":1139270400000},"content-version":"vor","delay-in-days":2808,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[1998,6]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Hepatitis C infection is common in patients receiving life\u2010long blood transfusion therapy. Interferon\u2010\u03b1 induces long\u2010term viral clearance in 25\u201030% of patients suffering from Cooley's anemia. Ribavirin, an orally active guanoside analogue together with interferon\u2010\u03b1 produces a sustained response in up to 40% of patients with cirrhosis, who had previously failed single agent treatment. Growth retardation in iron\u2010overloaded patients is the result of growth hormone deficiency in up to 30% of patients. Height gain can be sucessfully achieved in these patients with growth hormone treatment. Pregnancy in women with Cooley's anemia is now a reality, and over 100 pregnancies have been documented. Conception may be spontaneous or the result of ovulation induction. Cardiomyopathy and diabetes require careful assessment in these patients before a decision is made to treat with gonadotrophins to induce ovulation.<\/jats:p>","DOI":"10.1111\/j.1749-6632.1998.tb10480.x","type":"journal-article","created":{"date-parts":[[2006,2,7]],"date-time":"2006-02-07T09:37:23Z","timestamp":1139305043000},"page":"232-241","source":"Crossref","is-referenced-by-count":16,"title":["New Approaches to the Management of Hepatitis and Endocrine Disorders in Cooley's Anemia"],"prefix":"10.1111","volume":"850","author":[{"given":"BEATRIX","family":"WONKE","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. V.","family":"HOFFBRAND","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"BOULOUX","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"JENSEN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"TELFER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,2,7]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.43.8.638"},{"key":"e_1_2_5_3_2","first-page":"66","article-title":"Clinical experience of management of thalassaemia; The Sardinian experience","volume":"1","author":"Cao A.","year":"1996","journal-title":"Sem. Hematol."},{"key":"e_1_2_5_4_2","unstructured":"Bozkurt G. T. Dikengil O. Alimogluet al.1993. Hepatitis C among Turkish Cypriot Thalassemic Patients. Presented at Fifth International Conference on Thalassemias and Hemaglobinopathies. Nicosia Cyprus 1993. p. 176."},{"key":"e_1_2_5_5_2","unstructured":"Cancado R. D. L. G. M. Guerra M. O. J. A. Rosenfeldet al.1993. Prevalence of hepatitis C virus antibody in beta thalassaemic patients. Presented at Fifth International Conference on Thalassemias and Hemoglobinopathies. Nicosia Cyprus 1993. p. 176."},{"key":"e_1_2_5_6_2","unstructured":"Kaur P. & B. Kaur. 1995. Thalassemia in Penang. Presented at First Asian Congress on Thalassemia. Penang Malaysia. p. 70\u201372."},{"key":"e_1_2_5_7_2","first-page":"1681","article-title":"To C or not to C","volume":"85","author":"Alter H. J.","year":"1995","journal-title":"These are the questions. Blood"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)90264-X"},{"key":"e_1_2_5_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1993.tb04676.x"},{"key":"e_1_2_5_10_2","unstructured":"Rowntree C. P. T. Telfer B. Wonkeet al.1995. Long\u2010term follow up of alpha interferon therapy for chronic hepatitis C infection in thalassemic patients. Br. J. Haematol. (Supplement 1) Abstract 199: 55."},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1995.tb02683.x"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/12.6.1139"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840160307"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890410203"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2953112.x"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(94)90131-7"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.1890460110"},{"key":"e_1_2_5_18_2","unstructured":"Shulman N. R. 1984. Assessment of hematologic effects of ribavirin in humans.In: Clinical Applications of Ribavirin. R. Smith & V. Knight Eds.: 79\u201092. Academic Press. New York."},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb02514.x"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-62-2-263"},{"key":"e_1_2_5_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(80)80805-5"},{"key":"e_1_2_5_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(88)80375-5"},{"key":"e_1_2_5_23_2","unstructured":"De Sanctis V. & B. Wonke. 1994. Growth in Thalassemia. Mediprint. Rome."},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/archpedi.1927.04130210022002"},{"key":"e_1_2_5_25_2","doi-asserted-by":"crossref","unstructured":"Giardina P. J. R. Schneider M. Lesseret al.1995. Abnormal bone metabolism in thalassemia.InEndocrine Disorders in Thalassemia (pp. 38\u201046). Springer\u2010Verlag.","DOI":"10.1007\/978-88-470-2183-9_6"},{"key":"e_1_2_5_26_2","doi-asserted-by":"crossref","unstructured":"Goni M. H. V. Markussis & G. Tolis. 1995. Bone mineral content by single and dual\u2010photon absorptionmetry in thalassemic patients.InEndocrine Disorders in Thalassemia (pp. 47\u201051). Springer\u2010Verlag.","DOI":"10.1007\/978-88-470-2183-9_7"},{"key":"e_1_2_5_27_2","unstructured":"Jensen C. E. S. M. Tuck J. E. Agnewet al.1997. Osteoporosis in young adults with transfusion dependent b thalassemia major. Br. J. Haematol. (Submitted for publication.)."},{"key":"e_1_2_5_28_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.165.3899.1262"},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199007123230201"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.1998.tb10480.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.1998.tb10480.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T02:46:53Z","timestamp":1695696413000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.1998.tb10480.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["10.1111\/j.1749-6632.1998.tb10480.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.1998.tb10480.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}